From: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
Variable | Ischemia (N =56) | No ischemiaa (N = 60) | P value |
---|---|---|---|
Age, years | 64.1 (48.0, 77.1) | 63.0 (53.5, 73.3) | 0.808 |
Male, n (%) | 40 (71) | 41 (68) | 0.840 |
Surgical patient, n (%) | 21 (38) | 25 (42) | 0.706 |
APACHE II | 29.9 (7.5) | 27.4 (8.0) | 0.150 |
Preexisting conditions, n (%) | Â | Â | Â |
    Ischemic heart disease | 10 (18) | 4 (7) | 0.088 |
    Diabetes | 13 (23) | 10 (17) | 0.486 |
Baseline lactate | 2.0 (1.6, 4.5) | 2.6 (1.5, 3.9) | 0.441 |
More-severe shock,b n (%) | 28 (50) | 33 (55) | 0.710 |
Vasopressin, n (%) | 31 (55) | 32 (53) | 0.854 |
Days alive free of mechanical ventilation (first 28 days) | 0.0 (0.0, 13.0) | 2.0 (0.0, 17.0) | 0.165 |
ICU stay,c days | 13.0 (6.0, 31.0) | 11.5 (6.0, 20.0) | 0.518 |
Hospital stay,c days | 27.0 (11.0, 77.0) | 35.5 (16.0, 77.5) | 0.703 |
28-day mortality,d n (%) 95% CI | 26 (47) 34%-60% | 22 (37) 24%-49% | 0.263 |
90-day mortality,d n (%) 95% CI | 33 (60) 47% to 73% | 27 (45) 32% to 58% | 0.136 |